Regenovue Deep Plus Lidocaine (1×1.1ml)

Avoid alcohol for 24h before and 48h after the procedure. Alcohol is a vasodilator that can increase blood flow to the treated area, potentially worsening post-injection swelling and increasing the risk of significant bruising.

The formulation contains 24 mg/ml of monophasic cross-linked Hyaluronic Acid and 0.3% Lidocaine hydrochloride for a comfortable injection experience.

Dosage is individualized based on the depth of the skin depression and the desired level of volume. For nasolabial folds, a standard treatment involves 0.5 ml to 1.1 ml per side. Practitioners should evaluate if 0.5 ml of filler is sufficient for minor touch-ups before utilizing the full syringe capacity. For lip augmentation requiring a soft yet defined result, it may be alternated with Restylane Kysse.

Common reactions include temporary redness, swelling, and purple bruising at the injection site. These effects typically resolve within 7 days. Patients should follow our expert aftercare guide to ensure a smooth recovery. To minimize complications, clinicians must be proficient in techniques to avoid filler lumps and ensure proper product placement.

The gel acts as a mechanical support, physically filling the deep dermis or subcutaneous space. Its highly cross-linked HA matrix provides resistance to degradation, ensuring long-lasting volume. Unlike skin boosters that focus on dermal hydration, Regenovue Deep Plus focuses on structural augmentation. For patients with thinning skin, combining volume with Jalupro HMW can help improve skin density while the filler provides lift.

Treatment is strictly contraindicated. No clinical safety data exists for hyaluronic acid fillers during pregnancy or breastfeeding. We prioritize patient health and defer all aesthetic injections until after the nursing period has concluded to maintain the highest safety standards.